Silence Therapeutics (SLN) Gross Margin (2024 - 2026)

Silence Therapeutics (SLN) reported Gross Margin of 97.39% for Q1 2026, up 3542.0% on a YoY basis from 2.67% in Q1 2025, and up 50.52% sequentially from 64.71% in Q4 2025.

Silence Therapeutics (SLN) Gross Margin (2024 - 2026) Analysis & Trends

Silence Therapeutics (SLN) has 3 years of Gross Margin data on file, last reported at 97.39% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 3542.0% year-over-year to 97.39%; the trailing twelve-month figure through Mar 2026 stood at 79.5% (up 1233.0% YoY), and the FY2025 full-year result was 61.54%, down 1116.0% from the prior year.
  • Gross Margin advanced to 97.39% in Q1 2026, from 64.71% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 97.39% in Q1 2026 to a low of 322.12% in Q2 2024.
  • A 3-year average of 6.1% and a median of 62.05% in 2025 frame the typical range for Gross Margin.
  • Peak annual rise in Gross Margin reached 38418 bps in 2025, while the deepest fall reached 2724 bps in 2025.
  • Tracing SLN's Gross Margin over 3 years: stood at 91.95% in 2024, then declined by 30 bps to 64.71% in 2025, then soared by 51 bps to 97.39% in 2026.
  • Business Quant data shows SLN's Gross Margin at 97.39% in Q1 2026, 64.71% in Q4 2025, and 59.75% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Silence Therapeutics 1.62 Bn 1.49 Bn 411,000.00 97.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 97.39%
Dec 31, 2025 64.71%
Sep 30, 2025 59.75%
Jun 30, 2025 62.05%
Mar 31, 2025 61.97%
Dec 31, 2024 91.95%
Sep 30, 2024 -142.92%
Jun 30, 2024 -322.13%
Mar 31, 2024 82.16%